Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy |
| |
Authors: | Eain?M.?Cornford mailto:comford@ucla.edu" title=" comford@ucla.edu" itemprop=" email" data-track=" click" data-track-action=" Email author" data-track-label=" " >Email author,Shigeyo?Hyman |
| |
Affiliation: | 1.W127 Neurology,Veterans Affairs Greater Los Angeles Healthcare System,Los Angeles;2.Department of Neurology,UCLA School of Medicine,Los Angeles;3.The Brain Research Institute,UCLA School of Medicine,Los Angeles |
| |
Abstract: | Immunogold electron microscopy has identified a variety of blood-brain barrier (BBB) proteins with transporter and regulatory functions. For example, isoforms of the glucose transporter, protein kinase C (PKC), and caveolin-1 are BBB specific. Isoform 1 of the facilitative glucose transporter family (GLUT1) is expressed solely in endothelial (and pericyte) domains, and ∼75% of the protein is membrane-localized in humans. Evidence is presented for a water cotransport function of BBB GLUT1. A shift in transporter polarity characterized by increased luminal membrane GLUT1 is seen when BBB glucose transport is upregulated; but a greater abluminal membrane density is seen in the human BBB when GLUT1 is downregulated. PKC colocalizes with GLUT1 within these endothelial domains during up- and downregulation, suggesting that a PKC-mediated mechanism regulates human BBB glucose transporter expression. Occludin and claudin-5 (like other tight-junctional proteins) exhibit a restricted distribution, and are expressed solely within interendothelial clefts of the BBB. GFAP (glial fibrillary acidic protein) is uniformly expressed throughout the foot-processes and the entire astrocyte. But the microvascular-facing membranes of the glial processes that contact the basal laminae are also polarized, and their transporters may also redistribute within the astrocyte. Monocarboxylic acid transporter and water channel (Aquaporin-4) expression are enriched at the glial foot-process, and both undergo physiological modulation. We suggest that as transcytosis and efflux mechanisms generate interest as potential neurotherapeutic targets, electron microscopic confirmation of their site-specific expression patterns will continue to support the CNS drug discovery process. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|